 | Drug Molnupiravir effective against Omicron, could reduce deaths: StudyA new study revealed that a five-day course of antiviral drug, Molnupiravir, could be effective against highly contagious Omicron and other variants of concern (VOCs). |
 | 105 nations to get cheaper Merck Covid pill; molnupiravir not added to India's treatment protocol due to safety concernsHowever, due to safety concerns, India has not added Merck's pill to its national treatment protocol for the disease. |
 | COVID: Maharashtra government says Molnupiravir must be used with cautionHe said this drug has received emergency use authorization (from the Drug Controller General of India) and based on the opinion of some experts it has also been included in treatment protocol. |
| ICMR experts reject inclusion of Molnupiravir in Covid treatment guidelines for fourth time citing safety concernsIndia's drug regulator on December 28 had approved the anti-Covid pill for restricted use in emergency situations. |
| Molnupiravir not to be included in COVID-19 clinical management protocol as of nowThe experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday. |
| Self-medication with Molnupiravir can be dangerous: ExpertsDr Ravindra Mehta, Pulmonologist with Apollo Group of Hospitals, has warned people against using the drug unless prescribed by a medical practitioner. |
| Mild COVID cases can be managed at home, Molnupiravir no magic drug, says AIIMS doctorMolnupiravir works by inducing mutation in the virus by substituting one of the components that is also present in human genetic material. |
 | Lupin launches Molnulup for COVID-19 treatmentMolnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease. |
 | Covid antiviral drug Molnupiravir has major safety concerns: ICMR chiefDuring a press briefing, he said the World Health Organisation and the UK have not included it for treatment. |
| Aurobindo Pharma launches COVID-19 drug Molnupiravir in IndiaMolnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based drug maker said. |
 | Doctors have different views on new drugMolnupiravir, the antiviral drug for COVID-19, has hit the market within a week of receiving emergency use authorisation. |
 | Anti-COVID pill to be rolled out shortly; eight vaccines, four treatments now in India's arsenalStrides, Dr Reddy's, Sun Pharma, Cipla, Hetero, Torrent and Optimus said they have received approvals from the DCGI to manufacture and market their versions of Molnupiravir. |
 | Two more vaccines and a pill added to India's inventory to combat CovidDCGI on Tuesday gave emergency use authorisation (EUA) to Covid vaccines Covovax and Corbevax, apart from Covid drug molnupiravir. |
| Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyOptimus Pharma has revealed highly promising results of the drug in its ability to reduce viral load and bring out significant symptomatic improvement in patient's health. |
 | Boost for India's COVID fight as country approves vaccines Corbevax, Covovax and Molnupiravir pillWith this approval, the number of Covid vaccines which have received emergency use authorisation in the country has increased to eight. |
